AACT_HUMAN - dbPTM
AACT_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AACT_HUMAN
UniProt AC P01011
Protein Name Alpha-1-antichymotrypsin
Gene Name SERPINA3
Organism Homo sapiens (Human).
Sequence Length 423
Subcellular Localization Secreted.
Protein Description Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2..
Protein Sequence MERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
27PhosphorylationAVLCHPNSPLDEENL
HHHCCCCCCCCHHHC
31.1524505115
33N-linked_GlycosylationNSPLDEENLTQENQD
CCCCCHHHCCCCCCC
46.4716335952
33N-linked_GlycosylationNSPLDEENLTQENQD
CCCCCHHHCCCCCCC
46.4717623646
35PhosphorylationPLDEENLTQENQDRG
CCCHHHCCCCCCCCC
45.4826657352
93N-linked_GlycosylationFLSLGAHNTTLTEIL
HHHHCCCCCCHHHHH
33.9417623646
93N-linked_GlycosylationFLSLGAHNTTLTEIL
HHHHCCCCCCHHHHH
33.9417623646
106N-linked_GlycosylationILKGLKFNLTETSEA
HHHHCCCCCCCCCHH
44.4512754519
106N-linked_GlycosylationILKGLKFNLTETSEA
HHHHCCCCCCCCCHH
44.4518638581
127N-linked_GlycosylationQHLLRTLNQSSDELQ
HHHHHHHCCCCCHHC
38.7918638581
127N-linked_GlycosylationQHLLRTLNQSSDELQ
HHHHHHHCCCCCHHC
38.7916335952
158AcetylationDRFTEDAKRLYGSEA
HHHHHHHHHHHCCHH
56.0812438997
177AcetylationFQDSAAAKKLINDYV
CCCHHHHHHHHHHHH
43.3012439007
186N-linked_GlycosylationLINDYVKNGTRGKIT
HHHHHHHHCCCCCHH
47.2017623646
186N-linked_GlycosylationLINDYVKNGTRGKIT
HHHHHHHHCCCCCHH
47.2016335952
191AcetylationVKNGTRGKITDLIKD
HHHCCCCCHHHHHHH
38.8619814787
201PhosphorylationDLIKDLDSQTMMVLV
HHHHHCCHHHHHHHH
34.5425003641
203PhosphorylationIKDLDSQTMMVLVNY
HHHCCHHHHHHHHHH
15.9325003641
210PhosphorylationTMMVLVNYIFFKAKW
HHHHHHHHHHHHHCC
7.5128851738
226PhosphorylationMPFDPQDTHQSRFYL
CCCCCCCCCCHHEEC
19.3029083192
229PhosphorylationDPQDTHQSRFYLSKK
CCCCCCCHHEECCCC
19.4229083192
235AcetylationQSRFYLSKKKWVMVP
CHHEECCCCCEEEEE
56.6481933
236AcetylationSRFYLSKKKWVMVPM
HHEECCCCCEEEEEC
48.7981935
237AcetylationRFYLSKKKWVMVPMM
HEECCCCCEEEEECC
49.0881937
245PhosphorylationWVMVPMMSLHHLTIP
EEEEECCCCCCCCCC
20.4924505115
261S-nitrosylationFRDEELSCTVVELKY
CCCCCCCEEEEEEEE
5.3825040305
271N-linked_GlycosylationVELKYTGNASALFIL
EEEEECCCCEEEEEE
23.9516335952
271N-linked_GlycosylationVELKYTGNASALFIL
EEEEECCCCEEEEEE
23.9518638581
273PhosphorylationLKYTGNASALFILPD
EEECCCCEEEEEECC
29.51-
295PhosphorylationEAMLLPETLKRWRDS
HHHHCHHHHHHHHHH
35.3220363803
302PhosphorylationTLKRWRDSLEFREIG
HHHHHHHHHCHHHCC
22.6423911959
312PhosphorylationFREIGELYLPKFSIS
HHHCCCEECCCCEEC
19.3625690035
338PhosphorylationLGIEEAFTSKADLSG
HCCHHHHCCCCHHCC
36.04-
347PhosphorylationKADLSGITGARNLAV
CCHHCCCCCCHHHHH
28.4524505115
347O-linked_GlycosylationKADLSGITGARNLAV
CCHHCCCCCCHHHHH
28.4546286157
355PhosphorylationGARNLAVSQVVHKAV
CCHHHHHHHHHHHHH
16.2024505115
370PhosphorylationLDVFEEGTEASAATA
HHHHHHCCHHHHHHH
31.4924505115
373PhosphorylationFEEGTEASAATAVKI
HHHCCHHHHHHHHHH
16.5324505115
373O-linked_GlycosylationFEEGTEASAATAVKI
HHHCCHHHHHHHHHH
16.53OGP
381O-linked_GlycosylationAATAVKITLLSALVE
HHHHHHHHHHHHHHH
18.87OGP
381PhosphorylationAATAVKITLLSALVE
HHHHHHHHHHHHHHH
18.8724505115
384PhosphorylationAVKITLLSALVETRT
HHHHHHHHHHHHCCH
23.7524505115
389PhosphorylationLLSALVETRTIVRFN
HHHHHHHCCHHHCCC
26.1524505115
389O-linked_GlycosylationLLSALVETRTIVRFN
HHHHHHHCCHHHCCC
26.15OGP
416AcetylationQNIFFMSKVTNPKQA
CCEEEEECCCCCCCC
41.097782318
421AcetylationMSKVTNPKQA-----
EECCCCCCCC-----
62.017782318

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of AACT_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AACT_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AACT_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RPA12_HUMANZNRD1physical
21988832

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AACT_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93; ASN-106; ASN-127 ANDASN-271, AND MASS SPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-93; ASN-106;ASN-127; ASN-186 AND ASN-271, AND MASS SPECTROMETRY.
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry.";
Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
Proteomics 4:454-465(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-93 AND ASN-106.

TOP